Insuvia is designed to act as a pharmacovigilance and regulatory affairs unit for pharmaceutical companies in those countries and regions, where they have no internal structures or decide to focus their resources on commercial activities.
In this context, we provide the regional EU and country-level expertise to solve all pharmacovigilance and regulatory affairs challenges that pharmaceutical companies encounter while commercializing their products.
We specialize in local pharmacovigilance and regulatory operations. As part of this differentiation, we have built a local presence that is second to none. That means local resources who understand your business, local and international requirements and the specifics of the industry.
We believe that the management of pharmacovigilance and regulatory affairs on a global scale requires a structured and strategic service delivery approach. Our “Unified Governance Model” consolidates country-level and global activities into a seamless and fully integrated system.
Our vision is to be the leader for exceptional client service. This is not about reinventing our profession’s approach to service, but about delivering our services exceptionally well – and delivering that high quality consistently in every office, every country and every territory where we have a presence.
We have grown to an international organization by expanding to new territories step-by-step. This bottom-up approach has provided us with a unique understanding of each activity we are involved in, of each territory we operate in, as well as of the challenges our clients and industry face.
This was the foundation that made us who we are today – a prominent leader in the pharmacovigilance and regulatory affairs services industry, helping the pharmaceutical industry make safe and effective healthcare products available worldwide.
Establishing a company in Lithuania and starting to provide clinical research services for the pharmaceutical industry in the Baltic region.
Starting to provide pharmacovigilance and regulatory affairs services and to expand these services to first new territories.
Expanding our established local pharmacovigilance and local regulatory affairs services model across territories in the EU, CIS and MENA.
Our Quality Management System was ISO 9001:2015 certified by TÜV Thüringen for the scope of: Pharmacovigilance services, Regulatory Affairs services, Clinical Research services
Insuvia been named one of the 1000 fastest-growing companies in Europe by Financial Times, coming in at 367th place.
Chief Executive Officer
Responsible for leading the company towards achieving its long-term vision and strategic objectives. Donatas background includes a degree in Pharmacy and a degree in Economics, as well as over 10 years of experience in the pharmacovigilance and regulatory affairs industry.
Chief Operating Officer
Provides leadership to our operational teams and is actively involved in customer relations. Martynas is a pharmacist with over 10 years of experience in Pharmacovigilance and Regulatory Affairs. He has acted as the QPPV and led the development of PV systems for some of the most renowned companies.
In starting Insuvia, we wanted to create a pharmacovigilance and regulatory affairs service provider that delivers a unified system, standardized and customer-oriented service across all territories and levels of service. To make it our promise, we have translated this mission into the three Insuvia’s brand pillars – solid local presence, unified governance, and exceptional client service.
Donatas Grina
Chief Executive Officer